SABR for Oligometastases: Bibliometric Analysis of 1,066 Publications (2006-2025)

1,066 publications on Stereotactic Ablative Radiotherapy for oligometastatic cancer were analyzed from 2006 to 2025. The bibliometric analysis by Yupeng Di maps publication trends, key contributors, and research hotspots. It identifies the United States, Italy, and Canada as leading countries and highlights influential clinical trials like SABR-COMET and ORIOLE.

Use Cases

• Analyze publication growth trends in stereotactic radiotherapy research based on the 2006-2025 time range.
• Map collaboration networks among key authors and institutions like Humanitas University.
• Identify research hotspots based on keyword analysis of cancer types, metastatic sites, and treatment strategies.
• Study the citation impact of landmark clinical trials such as SABR-COMET and ORIOLE.

Strengths

• Analysis is based on 1,066 publications from Web of Science and PubMed.
• Covers a 20-year time range from 2006 to 2025.
• Identifies specific leading countries (United States, Italy, Canada) and institutions (Humanitas University).

Limitations

• Row count and column-level documentation for the underlying data are unknown.
• The 17.7 KB file size suggests a limited scope, likely containing summary statistics rather than raw publication data.
• Data may reflect the indexing bias inherent to the Web of Science and PubMed sources used.

Provenance

Source

Web of Science Core Collection and PubMed.

Collection Method

Cross-sectional bibliometric analysis using bibliometrix, VOSviewer, and CiteSpace.

Time Range

2006-01-01 to 2025-12-31

Freshness

Last updated 2026-03-18 05:34:41.

Geography

Global, with leading contributions from the United States, Italy, and Canada.